UTHR — UNITED THERAPEUTICS Corp

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1082554 ·
Last close
$584.10
Market Cap
$24.88B
52W High
$614.23
52W Low
$455.63
ADV30
596,185
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 832,500,000 733,400,000 241,300,000 258,600,000 7,034,100,000 1,188,900,000 758,100,000
Jun 2026 783,300,000 683,800,000 330,800,000 333,000,000 7,220,100,000 1,803,200,000 819,800,000
Mar 2026 781,500,000 648,100,000 325,800,000 274,900,000 6,714,200,000 1,279,700,000 813,100,000
Dec 2025 790,200,000 686,800,000 357,500,000 364,300,000 7,880,000,000 1,557,100,000 783,800,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,429,600,000
Investing CF
$93,000,000
Financing CF
$-1,673,800,000
CapEx
$-562,400,000
Dividends Paid
—
Buybacks
$-2,055,200,000
EPS Diluted TTM
$26.50
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$9,423,400,000
Inventory
$201,900,000
Receivables
$348,600,000
ST Investments
$879,000,000
EBIT TTM
$1,519,700,000
Pretax Income TTM
$1,507,800,000
Interest Exp TTM
$11,900,000
Analysts
14

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,187,500,032
EBITDA
$1,351,299,968
Free Cash Flow
$454,624,992
Enterprise Value
$21,867,814,912
Total Cash
$2,067,900,032
Total Debt
$0
Shares Out
42,588,726
Trailing EPS
$26.49
Book Value
$148.08
ROE
19.1%
ROA
10.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 3,182,700,000 1,517,200,000 1,334,700,000 7,880,000,000 783,800,000 7,096,200,000 1,561,200,000
Dec 2024 2,877,400,000 1,448,100,000 1,195,100,000 7,364,000,000 920,000,000 6,444,000,000 1,327,100,000
Dec 2023 2,327,500,000 1,184,900,000 984,800,000 7,167,000,000 1,182,200,000 5,984,800,000 978,000,000
Dec 2022 1,936,300,000 979,700,000 727,300,000 6,044,500,000 1,247,800,000 4,796,700,000 802,500,000

TTM Snapshot

Revenues TTM
$3,154,500,000
NetIncome TTM
$1,310,900,000
OpCashFlow TTM
—
Assets (Latest)
$7,220,100,000
Forward EPS
$33.89

Max Pain — expiry 2027-01-15

max pain strike: $560.00 · spot: $577.34 · call oi: 1,857 · put oi: 608
Expected Move to 2027-01-15: ±$57.46 (9.95%) — implied range $519.88 – $634.80 · ATM straddle on $580.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
VTRS Viatris Inc $23.45B $20.45 —
INSM INSMED Inc $26.73B $121.86 —
ROIV Roivant Sciences Ltd. $28.05B $38.71 —
ALNY ALNYLAM PHARMACEUTICALS, INC. $20.96B $156.50 —
RPRX Royalty Pharma plc $30.58B $68.68 —

News headlines (Yahoo Finance, 1h cache)

iShares Core S&P Mid-Cap (IJH) Adds Chime Financial on Tuesday
2026-11-19 11:04 · Yahoo
United Therapeutics Prepares for TYVASO Expansion After $833 Million Quarter
2026-11-17 03:12 · Yahoo
SGIOY or UTHR: Which Is the Better Value Stock Right Now?
2026-11-16 15:40 · Yahoo
What iShares S&P Mid-Cap 400 Growth ETF (IJK) Bought: FTI Leads on Tuesday
2026-11-12 11:05 · Yahoo
iShares Core S&P Mid-Cap (IJH) Adds TechnipFMC and United Therapeutics on Tuesday
2026-11-12 11:04 · Yahoo
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
2026-11-09 12:00 · Yahoo
The 5 most interesting analyst questions from United Therapeutics’s Q3 2026 earnings call
2026-11-08 22:37 · Yahoo
SPDR S&P MidCap 400 ETF (MDY) Adds Glaukos and United Therapeutics on Wednesday
2026-11-06 11:04 · Yahoo
MannKind Sees Q4 Profit and Record Revenue as Drug Launches Gain Traction
2026-11-18 12:13 · Yahoo
iShares Core S&P Mid-Cap (IJH) Sells ATI and TechnipFMC on Nov. 12
2026-11-16 11:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.